CRISM Therapeutics (CRTX) Competitors GBX 23 -1.80 (-7.26%) As of 12:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock CRTX vs. GLR, PXC, BRES, TGR, CLA, VAST, BMN, SML, PREM, and FRGShould you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include Galileo Resources (GLR), Phoenix Copper (PXC), Blencowe Resources (BRES), Tirupati Graphite (TGR), Celsius Resources (CLA), Vast Resources (VAST), Bushveld Minerals (BMN), Strategic Minerals (SML), Premier African Minerals (PREM), and Firering Strategic Minerals (FRG). These companies are all part of the "other industrial metals & mining" industry. CRISM Therapeutics vs. Its Competitors Galileo Resources Phoenix Copper Blencowe Resources Tirupati Graphite Celsius Resources Vast Resources Bushveld Minerals Strategic Minerals Premier African Minerals Firering Strategic Minerals CRISM Therapeutics (LON:CRTX) and Galileo Resources (LON:GLR) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, community ranking, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Does the media favor CRTX or GLR? In the previous week, CRISM Therapeutics had 1 more articles in the media than Galileo Resources. MarketBeat recorded 1 mentions for CRISM Therapeutics and 0 mentions for Galileo Resources. CRISM Therapeutics' average media sentiment score of 1.38 beat Galileo Resources' score of 0.00 indicating that CRISM Therapeutics is being referred to more favorably in the media. Company Overall Sentiment CRISM Therapeutics Positive Galileo Resources Neutral Do institutionals and insiders hold more shares of CRTX or GLR? 8.9% of Galileo Resources shares are held by institutional investors. 68.8% of CRISM Therapeutics shares are held by company insiders. Comparatively, 74.8% of Galileo Resources shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings & valuation, CRTX or GLR? Galileo Resources is trading at a lower price-to-earnings ratio than CRISM Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCRISM TherapeuticsN/AN/A-£792.20K-£5.81-3.96Galileo ResourcesN/AN/A-£1.05M-£0.09-9.57 Which has more risk and volatility, CRTX or GLR? CRISM Therapeutics has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, Galileo Resources has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500. Does the MarketBeat Community prefer CRTX or GLR? Galileo Resources received 85 more outperform votes than CRISM Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformCRISM TherapeuticsN/AN/AGalileo ResourcesOutperform Votes8559.86% Underperform Votes5740.14% Is CRTX or GLR more profitable? Galileo Resources' return on equity of -9.30% beat CRISM Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CRISM TherapeuticsN/A -13.12% -26.77% Galileo Resources N/A -9.30%-4.51% SummaryGalileo Resources beats CRISM Therapeutics on 7 of the 11 factors compared between the two stocks. Get CRISM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRTX vs. The Competition Export to ExcelMetricCRISM TherapeuticsOther Industrial Metals & Mining IndustryMaterials SectorLON ExchangeMarket Cap£2.51M£1.03B£3.20B£2.92BDividend YieldN/A6.20%5.03%4.90%P/E Ratio-3.9654.7464.60119.50Price / SalesN/A20,604.9326,914,679,906,558,600.00242,015.15Price / CashN/A24.7024.2628.07Price / Book0.536.735.394.73Net Income-£792.20K£71.37M£155.18M£5.91B7 Day Performance21.05%0.44%1.13%6.51%1 Month Performance27.78%9.37%8.99%13.46%1 Year PerformanceN/A31.09%23.21%28.79% CRISM Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRTXCRISM TherapeuticsN/AGBX 23-7.3%N/AN/A£2.51MN/A-3.964Positive NewsEarnings ReportHigh Trading VolumeGLRGalileo ResourcesN/AGBX 0.92-0.5%N/A-12.4%£10.70MN/A-10.171PXCPhoenix CopperN/AGBX 4.66-11.3%N/A-80.4%£10.02MN/A-4.0818Gap DownHigh Trading VolumeBRESBlencowe ResourcesN/AGBX 3.36+8.5%N/A-37.2%£9.96MN/A-7.783Gap UpHigh Trading VolumeTGRTirupati GraphiteN/AN/AN/AN/A£8.67M£4.38M-2.4136,000CLACelsius ResourcesN/AGBX 0.33flatN/A-43.5%£8.35M£647.000.00N/AGap UpVASTVast ResourcesN/AGBX 0.44-1.8%N/A+134.2%£8M£3.58M-44.20350News CoverageGap DownBMNBushveld MineralsN/AN/AN/AN/A£7.07M£107.92M-5.10758SMLStrategic MineralsN/AGBX 0.28-3.4%N/A+51.4%£7.06M£4.65M-0.6511Gap DownPREMPremier African MineralsN/AGBX 0.01flatN/A-88.1%£6.18MN/A-0.1919High Trading VolumeFRGFirering Strategic MineralsN/AGBX 2.78-0.9%N/A-15.9%£6.12MN/A-2.37N/AHigh Trading Volume Related Companies and Tools Related Companies Galileo Resources Alternatives Phoenix Copper Alternatives Blencowe Resources Alternatives Tirupati Graphite Alternatives Celsius Resources Alternatives Vast Resources Alternatives Bushveld Minerals Alternatives Strategic Minerals Alternatives Premier African Minerals Alternatives Firering Strategic Minerals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CRTX) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSomething Big Is Coming...Man who predicted Lehman Crash Warns "Get OUT of Cash" He predicted the 2008 crisis and recommended shortin...Stansberry Research | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. Chinese AI chatbot DeepSeek turned the tech world on its hea...Weiss Ratings | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.